Dimethylbarbituric acid → Allyl 4-[({(2S,4R)-1-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-2-propenoyl}-4-[1-(methylsulfonyl)-4-piperidinyl]-2-pyrrolidinyl}carbonyl)amino]benzoate

HRID 1053845노트

반응식

HRID 1053845 반응식
CC(O[C:6]([N:8]1[CH2:12][C@@H:11]([CH:13]2[CH2:18][CH2:17][N:16]([S:19]([CH3:22])(=[O:21])=[O:20])[CH2:15][CH2:14]2)[CH2:10][C@H:9]1[C:23]([OH:25])=[O:24])=[O:7])(C)C.[NH2:26][C:27]1[CH:38]=[CH:37][C:30]([C:31]([O:33][CH2:34][CH:35]=[CH2:36])=[O:32])=[CH:29][CH:28]=1.[Cl:39][C:40]1[CH:41]=[CH:42][C:43]([N:51]2[CH:55]=[N:54][N:53]=[N:52]2)=[C:44](/[CH:46]=[CH:47]/[C:48]([OH:50])=O)[CH:45]=1.CN1C(=O)CC(=O)N(C)C1=O>CN(C)C=O.C(OC(C)C)(C)C.ClCCl.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[Cl:39][C:40]1[CH:41]=[CH:42][C:43]([N:51]2[CH:55]=[N:54][N:53]=[N:52]2)=[C:44](/[CH:46]=[CH:47]/[C:6]([N:8]2[CH2:12][C@@H:11]([CH:13]3[CH2:14][CH2:15][N:16]([S:19]([CH3:22])(=[O:20])=[O:21])[CH2:17][CH2:18]3)[CH2:10][C@H:9]2[C:23]([NH:26][C:27]2[CH:28]=[CH:29][C:30]([C:31]([O:33][CH2:34][CH:35]=[CH2:36])=[O:32])=[CH:37][CH:38]=2)=[O:25])=[O:7])[CH:45]=1.[Cl:39][C:40]1[CH:41]=[CH:42][C:43]([N:51]2[CH:55]=[N:54][N:53]=[N:52]2)=[C:44](/[CH:46]=[CH:47]/[C:48]([N:8]2[CH2:12][C@@H:11]([CH:13]3[CH2:18][CH2:17][N:16]([S:19]([CH3:22])(=[O:21])=[O:20])[CH2:15][CH2:14]3)[CH2:10][C@H:9]2[C:23]([NH:26][C:27]2[CH:28]=[CH:29][C:30]([C:31]([OH:33])=[O:32])=[CH:37][CH:38]=2)=[O:24])=[O:50])[CH:45]=1

참가 물질

10

반응물 4

HCID 69860Dimethylbarbituric acidHCID 13075143Prop-2-en-1-yl 4-aminobenzoateHCID 66698416(E)-3-(5-chloro-2-(1H-tetrazol-1-yl)phenyl)acrylic acidHCID 118107723(2S,4R)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-[1-(methylsulfonyl)-4-piperidinyl]-2-pyrrolidinecarboxylic acid

생성물 2

HCID 90022958Allyl 4-[({(2S,4R)-1-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-2-propenoyl}-4-[1-(methylsulfonyl)-4-piperidinyl]-2-pyrrolidinyl}carbonyl)amino]benzoateHCID 900238494-[({(2S,4R)-1-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-2-propenoyl}-4-[1-(methylsulfonyl)-4-piperidinyl]-2-pyrrolidinyl}carbonyl)amino]benzoic acid

시약·촉매·용매 4

HCID 178418397HCID 178418397, 화합물촉매2회HCID 6228Dimethylformamide용매HCID 6344Dichloromethane용매HCID 7914Diisopropyl Ether용매

실험 절차

Allyl 4-[({(2S,4R)-1-{(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-2-propenoyl}-4-[1-(methylsulfonyl)-4-piperidinyl]-2-pyrrolidinyl}carbonyl)amino]benzoate was prepared by following the procedures described in Examples 5, 9 and 8 starting from the compound prepared in Example 63. (Note: in the step corresponding to Example 5, allyl 4-aminobenzoate was used in place of tert-butyl 4-aminobenzoate. In the step corresponding to Example 8, (2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]acrylic acid was used in place of 1-(N,N′-bis(tert-butoxycarbonyl)carbamimidoyl)piperidine-4-carboxylic acid). After that, to a solution of the crude allyl ester (48 mg) in N,N-dimethylformamide (1 mL) was added tetrakis(triphenylphosphine)palladium(0) (2 mg) and 1,3-dimethylbarbituric acid (4 mg) and the reaction stirred overnight at room temperature. Further tetrakis(triphenylphosphine)palladium(0) (3 mg) was added at this juncture and stirring continued at room temperature for 7 h. The reaction mixture was left to stand overnight, diluted with a 1:1 mixture of diisopropylether and dichloromethane (1 mL) and the resulting precipitate collected by filtration. The yellow powder obtained was washed with dichloromethane and dried to give the title compound having the following physical properties (25 mg).

후처리

  1. stirringstirring
  2. waitcontinued at room temperature for 7 h
  3. waitThe reaction mixture was left
  4. waitto stand overnight
  5. filtrationthe resulting precipitate collected by filtration
  6. customThe yellow powder obtained
  7. washwas washed with dichloromethane
  8. customdried

출처 및 근거

ORD 기록
ord-3a2aea6c3f074dc2b1e960cc3ceb87ac
출처 데이터셋
uspto-grants-2016_07
특허 번호
US09394250B2

반응 노트

불러오는 중…